Summit Corporation plc Stock London S.E.
Stocks
GB00B02T3K57
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| Market Cap | 10.16B 13.42B 11.92B 11.15B 19.13B 1,292B 19.39B 135B 52.22B 658B 50.4B 49.31B 2,114B | P/E 2026 * |
-14.7x | P/E 2027 * | -14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 9.69B 12.8B 11.37B 10.63B 18.24B 1,233B 18.5B 129B 49.8B 628B 48.07B 47.03B 2,016B | EV / Sales 2026 * |
3,305x | EV / Sales 2027 * | 238x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Corporation plc
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 55 | 2022-07-24 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 2020-03-31 |
| Director of Finance/CFO | 48 | 2024-04-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 2020-01-31 |
| Director/Board Member | 48 | 2019-11-30 | |
Mahkam Zanganeh
BRD | Director/Board Member | 55 | 2020-11-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -5.20% | +27.94% | +34.47% | 44.25B | |
| +0.31% | +3.02% | +348.95% | +686.74% | 43.99B | |
| -1.96% | -0.33% | +7.04% | +100.99% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +328.03% | 24.93B | |
| Average | -0.04% | +1.97% | +55.30% | +159.21% | 44.09B | |
| Weighted average by Cap. | +0.18% | +1.83% | +60.00% | +150.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.93M 3.87M 3.44M 3.22M 5.52M 373M 5.6M 38.92M 15.07M 190M 14.54M 14.23M 610M | 41.86M 55.3M 49.12M 45.94M 78.81M 5.32B 79.89M 556M 215M 2.71B 208M 203M 8.71B |
| Net income | -698M -922M -819M -766M -1.31B -88.79B -1.33B -9.27B -3.59B -45.22B -3.46B -3.39B -145B | -740M -978M -869M -812M -1.39B -94.17B -1.41B -9.83B -3.8B -47.96B -3.67B -3.59B -154B |
| Net Debt | -470M -621M -551M -516M -885M -59.77B -897M -6.24B -2.41B -30.44B -2.33B -2.28B -97.78B | -200M -264M -235M -220M -377M -25.46B -382M -2.66B -1.03B -12.96B -993M -971M -41.64B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
